Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
BAXTER INTERNATIONAL INC
Report date January 31, 2025 · Filed February 04, 2025
Section 16 reporting ended · disclosed 2025-02-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $1 par valueSEC Table I · non-derivative | Direct | 105,186 |
Reported balance
After 2025-01-31 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-01-31 · Tax withholding · Disposed 25,372 · Balance 105,186 F1: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on January 31, 2025 from the settlement of restricted stock units granted on March 6, 2024. These shares vested on January 31, 2025 in accordance with the terms of that Equity Purchase Agreement, dated as of August 12, 2024 (as amended), by and among Baxter International Inc. and certain Carlyle affiliates (the "EPA"). F2: Adjusted to reflect (i) automatic reinvestment of dividends, and (ii) the number of shares forfeited by the reporting person in connection with the closing of the EPA, as further described in the Issuer's Form 8-K filed on February 3, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on January 31, 2025 from the settlement of restricted stock units granted on March 6, 2024. These shares vested on January 31, 2025 in accordance with the terms of that Equity Purchase Agreement, dated as of August 12, 2024 (as amended), by and among Baxter International Inc. and certain Carlyle affiliates (the "EPA").
F2: Adjusted to reflect (i) automatic reinvestment of dividends, and (ii) the number of shares forfeited by the reporting person in connection with the closing of the EPA, as further described in the Issuer's Form 8-K filed on February 3, 2025.
VARIAN MEDICAL SYSTEMS INC
Report date April 15, 2021 · Filed April 16, 2021
Section 16 reporting ended · disclosed 2021-04-16. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 1
1 source rowRow 1 · 2021-04-15 · Disposition to issuer · Disposed 15,418 · Balance 0 F1: Amount of securities disposed of reflect 196 shares purchased on April 8, 2021 under the Varian Medical Systems, Inc. Employee Stock Purchase Plan and a reduction of 8 shares as a result of a tax correction for the February 16, 2021 RSU vesting. F2: Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-04-15 · Disposition to issuer · Disposed 633 · Balance 0 F3: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F4: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning February 14, 2020, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-04-15 · Disposition to issuer · Disposed 1,816 · Balance 0 F3: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F5: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning February 15, 2021, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock. |
| Performance SharesSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-04-15 · Disposition to issuer · Disposed 6,415 · Balance 0 F6: Each performance stock unit represents a contingent right to receive one share of VAR common stock. F7: Pursuant to the Merger Agreement, these performance stock units, which were granted November 15, 2018, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level. |
| Performance SharesSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-04-15 · Disposition to issuer · Disposed 8,437 · Balance 0 F6: Each performance stock unit represents a contingent right to receive one share of VAR common stock. F8: Pursuant to the Merger Agreement, these performance stock units, which were granted November 21, 2019, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level. |
Filing footnotes · ownership attribution and instrument terms
F1: Amount of securities disposed of reflect 196 shares purchased on April 8, 2021 under the Varian Medical Systems, Inc. Employee Stock Purchase Plan and a reduction of 8 shares as a result of a tax correction for the February 16, 2021 RSU vesting.
F2: Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock.
F3: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.
F4: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning February 14, 2020, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock.
F5: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning February 15, 2021, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock.
F6: Each performance stock unit represents a contingent right to receive one share of VAR common stock.
F7: Pursuant to the Merger Agreement, these performance stock units, which were granted November 15, 2018, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level.
F8: Pursuant to the Merger Agreement, these performance stock units, which were granted November 21, 2019, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 06, 2019 Filed Dec 10, 2019 18:22 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 145 | $139.38 | $20,209.81 |
DisclosureSEC source: 0001127602-19-034709 · form4.xml · nonDerivative · entry 2 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,685 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F3 · price: The 145 shares were sold in multiple transactions executed on the same day at prices ranging from $139.02 to $139.95. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| December 06, 2019 Filed Dec 10, 2019 18:22 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 419 | $138.80 | $58,156.45 |
DisclosureSEC source: 0001127602-19-034709 · form4.xml · nonDerivative · entry 1 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,830 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · price: The 419 shares were sold in multiple transactions executed on the same day at prices ranging from $138.53 to $138.99. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| November 21, 2019 Filed Nov 25, 2019 17:02 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Tax withholdingCommon Stock | 719 | $129.97 | $93,448.43 |
DisclosureSEC source: 0001127602-19-033688 · form4.xml · nonDerivative · entry 2 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,249 F2 · shares: Represents shares withheld from vested PSU's for the payment of federal, state and payroll taxes due on settlement. Read SEC document |
| November 21, 2019 Filed Nov 25, 2019 17:02 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantCommon Stock | 1,847 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-033688 · form4.xml · nonDerivative · entry 1 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,968 F1 · shares: Represents shares issued upon settlement of performance-based unit award (PSUs) granted on December 8, 2016. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 19:29 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 1,400 | $0.00 Strike: $112.82 | $0.00 |
DisclosureSEC source: 0001127602-19-014336 · form4.xml · derivative · entry 3 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,391 Underlying: Common Stock · 1,400 shares Expires 2025-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Fifth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on February 8, 2019, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 19:29 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 1,400 | $142.50 | $199,500.00 |
DisclosureSEC source: 0001127602-19-014336 · form4.xml · nonDerivative · entry 2 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,121 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 19:29 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 1,400 | $112.82 | $157,948.00 |
DisclosureSEC source: 0001127602-19-014336 · form4.xml · nonDerivative · entry 1 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,521 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| March 22, 2019 Filed Mar 25, 2019 19:48 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 1,400 | $0.00 Strike: $112.82 | $0.00 |
DisclosureSEC source: 0001127602-19-013171 · form4.xml · derivative · entry 6 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,791 Underlying: Common Stock · 1,400 shares Expires 2025-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F3 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Fifth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on February 8, 2019, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| March 22, 2019 Filed Mar 25, 2019 19:48 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 1,400 | $140.00 | $196,000.00 |
DisclosureSEC source: 0001127602-19-013171 · form4.xml · nonDerivative · entry 4 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,121 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| March 22, 2019 Filed Mar 25, 2019 19:48 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 1,400 | $112.82 | $157,948.00 |
DisclosureSEC source: 0001127602-19-013171 · form4.xml · nonDerivative · entry 3 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,521 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| March 21, 2019 Filed Mar 25, 2019 19:48 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 1,211 | $0.00 Strike: $80.40 | $0.00 |
DisclosureSEC source: 0001127602-19-013171 · form4.xml · derivative · entry 5 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,823 Underlying: Common Stock · 1,211 shares Expires 2024-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Fourth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/10/2018, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| March 21, 2019 Filed Mar 25, 2019 19:48 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 1,211 | $137.50 | $166,512.50 |
DisclosureSEC source: 0001127602-19-013171 · form4.xml · nonDerivative · entry 2 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,121 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| March 21, 2019 Filed Mar 25, 2019 19:48 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 1,211 | $80.40 | $97,364.40 |
DisclosureSEC source: 0001127602-19-013171 · form4.xml · nonDerivative · entry 1 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,332 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 17:02 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 300 | $0.00 Strike: $80.40 | $0.00 |
DisclosureSEC source: 0001127602-19-012453 · form4.xml · derivative · entry 24 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,034 Underlying: Common Stock · 300 shares Expires 2024-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F12 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Fourth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/10/2018, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 17:02 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 900 | $0.00 Strike: $80.40 | $0.00 |
DisclosureSEC source: 0001127602-19-012453 · form4.xml · derivative · entry 23 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,334 Underlying: Common Stock · 900 shares Expires 2024-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F12 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Fourth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/10/2018, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 17:02 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 400 | $0.00 Strike: $67.12 | $0.00 |
DisclosureSEC source: 0001127602-19-012453 · form4.xml · derivative · entry 22 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 400 shares Expires 2023-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F11 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/12/2017, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 17:02 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 798 | $0.00 Strike: $67.12 | $0.00 |
DisclosureSEC source: 0001127602-19-012453 · form4.xml · derivative · entry 21 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400 Underlying: Common Stock · 798 shares Expires 2023-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F11 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/12/2017, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 17:02 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 108 | $0.00 Strike: $67.12 | $0.00 |
DisclosureSEC source: 0001127602-19-012453 · form4.xml · derivative · entry 20 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,198 Underlying: Common Stock · 108 shares Expires 2023-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F11 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/12/2017, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 17:02 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 300 | $0.00 Strike: $67.12 | $0.00 |
DisclosureSEC source: 0001127602-19-012453 · form4.xml · derivative · entry 19 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,306 Underlying: Common Stock · 300 shares Expires 2023-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F11 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/12/2017, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 17:02 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 692 | $0.00 Strike: $67.12 | $0.00 |
DisclosureSEC source: 0001127602-19-012453 · form4.xml · derivative · entry 18 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,606 Underlying: Common Stock · 692 shares Expires 2023-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F11 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/12/2017, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 17:02 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 100 | $136.70 | $13,670.00 |
DisclosureSEC source: 0001127602-19-012453 · form4.xml · nonDerivative · entry 17 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,121 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 17:02 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 300 | $136.02 | $40,805.01 |
DisclosureSEC source: 0001127602-19-012453 · form4.xml · nonDerivative · entry 16 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,221 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F10 · price: The 300 shares were sold in multiple transactions executed on the same day at prices ranging from $135.67 to $136.36. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 17:02 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 723 | $134.52 | $97,260.06 |
DisclosureSEC source: 0001127602-19-012453 · form4.xml · nonDerivative · entry 15 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,521 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F9 · price: The 723 shares were sold in multiple transactions executed on the same day at prices ranging from $134.01 to $134.78. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 17:02 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 300 | $136.37 | $40,911.00 |
DisclosureSEC source: 0001127602-19-012453 · form4.xml · nonDerivative · entry 14 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,244 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F8 · price: The 300 shares were sold in multiple transactions executed on the same day at prices ranging from $136.06 to $136.69. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 17:02 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 300 | $80.40 | $24,120.00 |
DisclosureSEC source: 0001127602-19-012453 · form4.xml · nonDerivative · entry 13 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,544 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 17:02 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 900 | $135.08 | $121,574.97 |
DisclosureSEC source: 0001127602-19-012453 · form4.xml · nonDerivative · entry 12 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,244 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F7 · price: The 900 shares were sold in multiple transactions executed on the same day at prices ranging from $135.00 to $135.69. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 17:02 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 900 | $80.40 | $72,360.00 |
DisclosureSEC source: 0001127602-19-012453 · form4.xml · nonDerivative · entry 11 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,144 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 17:02 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 400 | $136.19 | $54,476.00 |
DisclosureSEC source: 0001127602-19-012453 · form4.xml · nonDerivative · entry 10 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,244 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F6 · price: The 400 shares were sold in multiple transactions executed on the same day at prices ranging from $135.69 to $136.69. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 17:02 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 400 | $67.12 | $26,848.00 |
DisclosureSEC source: 0001127602-19-012453 · form4.xml · nonDerivative · entry 9 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,644 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 17:02 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 798 | $134.50 | $107,332.20 |
DisclosureSEC source: 0001127602-19-012453 · form4.xml · nonDerivative · entry 8 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,244 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F5 · price: The 798 shares were sold in multiple transactions executed on the same day at prices ranging from $134.32 to $134.78. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 17:02 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 798 | $67.12 | $53,561.76 |
DisclosureSEC source: 0001127602-19-012453 · form4.xml · nonDerivative · entry 7 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,042 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 17:02 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 108 | $136.68 | $14,761.08 |
DisclosureSEC source: 0001127602-19-012453 · form4.xml · nonDerivative · entry 6 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,244 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F4 · price: The 108 shares were sold in multiple transactions executed on the same day at prices ranging from $136.61 to $136.85. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 17:02 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 108 | $67.12 | $7,248.96 |
DisclosureSEC source: 0001127602-19-012453 · form4.xml · nonDerivative · entry 5 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,352 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 17:02 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 300 | $135.98 | $40,793.01 |
DisclosureSEC source: 0001127602-19-012453 · form4.xml · nonDerivative · entry 4 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,244 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F3 · price: The 300 shares were sold in multiple transactions executed on the same day at prices ranging from $135.52 to $136.39. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 17:02 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 300 | $67.12 | $20,136.00 |
DisclosureSEC source: 0001127602-19-012453 · form4.xml · nonDerivative · entry 3 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,544 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 17:02 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 692 | $134.47 | $93,049.78 |
DisclosureSEC source: 0001127602-19-012453 · form4.xml · nonDerivative · entry 2 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,244 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · price: The 692 shares were sold in multiple transactions executed on the same day at prices ranging from $134.22 to $134.62. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 17:02 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 692 | $67.12 | $46,447.04 |
DisclosureSEC source: 0001127602-19-012453 · form4.xml · nonDerivative · entry 1 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,936 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 18:46 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionRestricted Stock Units · Derivative | 1,656 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-007294 · form4.xml · derivative · entry 7 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93 Underlying: Common Stock · 1,656 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F5 · derivative.exercise_date: The restricted stock units vest in three equal installments on February 15, 2017, February 15, 2018, and February 15, 2019. Vested shares will be delivered to the reporting person on vest date. F5 · derivative.expiration_date: The restricted stock units vest in three equal installments on February 15, 2017, February 15, 2018, and February 15, 2019. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 18:46 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionRestricted Stock Units · Derivative | 967 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-007294 · form4.xml · derivative · entry 6 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,749 Underlying: Common Stock · 967 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F4 · derivative.exercise_date: The restricted stock units vest in three equal installments on February 15, 2018, February 15, 2019, and February 15, 2020. Vested shares will be delivered to the reporting person on vest date. F4 · derivative.expiration_date: The restricted stock units vest in three equal installments on February 15, 2018, February 15, 2019, and February 15, 2020. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 18:46 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionRestricted Stock Units · Derivative | 837 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-007294 · form4.xml · derivative · entry 5 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,716 Underlying: Common Stock · 837 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F3 · derivative.exercise_date: The restricted stock units vest in three equal installments on February 15, 2019, February 15, 2020, and February 15, 2021. Vested shares will be delivered to the reporting person on vest date. F3 · derivative.expiration_date: The restricted stock units vest in three equal installments on February 15, 2019, February 15, 2020, and February 15, 2021. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 18:46 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Tax withholdingCommon Stock | 1,216 | $132.74 | $161,411.84 |
DisclosureSEC source: 0001127602-19-007294 · form4.xml · nonDerivative · entry 4 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,244 F2 · price: Represents shares withheld from vested restricted stock units for the payment of federal, state and payroll taxes due on vesting. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 18:46 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 1,656 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-007294 · form4.xml · nonDerivative · entry 3 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,460 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 18:46 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 967 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-007294 · form4.xml · nonDerivative · entry 2 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,804 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 18:46 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 837 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-007294 · form4.xml · nonDerivative · entry 1 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 837 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 19:40 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantRestricted Stock Units · Derivative | 1,897 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-006983 · form4.xml · derivative · entry 2 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,553 Underlying: Common Stock · 1,897 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F2 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F3 · derivative.exercise_date: The restricted stock units vest in three equal installments on February 14, 2020, February 14, 2021, and February 14, 2022. Vested shares will be delivered to the reporting person on vest date. F3 · derivative.expiration_date: The restricted stock units vest in three equal installments on February 14, 2020, February 14, 2021, and February 14, 2022. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 19:40 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantNon Qualified Stock Option (Right to Buy) · Derivative | 8,573 | $0.00 Strike: $131.77 | $0.00 |
DisclosureSEC source: 0001127602-19-006983 · form4.xml · derivative · entry 1 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,573 Underlying: Common Stock · 8,573 shares Expires 2026-02-14 F1 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Fifth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on February 14, 2020, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.